BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34933064)

  • 1. Bacteria and bacterial derivatives as delivery carriers for immunotherapy.
    Kang SR; Nguyen DH; Yoo SW; Min JJ
    Adv Drug Deliv Rev; 2022 Feb; 181():114085. PubMed ID: 34933064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of bacteria as diagnostics and therapeutics by genetic engineering.
    Lim D; Song M
    J Microbiol; 2019 Aug; 57(8):637-643. PubMed ID: 31079333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a new class of engineered live bacterial therapeutics to treat human diseases.
    Charbonneau MR; Isabella VM; Li N; Kurtz CB
    Nat Commun; 2020 Apr; 11(1):1738. PubMed ID: 32269218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered microbial systems for advanced drug delivery.
    Shen H; Aggarwal N; Wun KS; Lee YS; Hwang IY; Chang MW
    Adv Drug Deliv Rev; 2022 Aug; 187():114364. PubMed ID: 35654214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic Bacteria for Therapeutics.
    Vo P; Lee HM; Na D
    J Microbiol Biotechnol; 2019 Jun; 29(6):845-855. PubMed ID: 31216840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic microbes as drug delivery systems.
    Claesen J; Fischbach MA
    ACS Synth Biol; 2015 Apr; 4(4):358-64. PubMed ID: 25079685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic biology expands chemical control of microorganisms.
    Ford TJ; Silver PA
    Curr Opin Chem Biol; 2015 Oct; 28():20-8. PubMed ID: 26056951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancement of Engineered Bacteria for Orally Delivered Therapeutics.
    Guo P; Wang S; Yue H; Zhang X; Ma G; Li X; Wei W
    Small; 2023 Nov; 19(48):e2302702. PubMed ID: 37537714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriosomes as a Promising Tool in Biomedical Applications: Immunotherapy and Drug Delivery.
    Harisa GI; Sherif AY; Youssof AME; Alanazi FK; Salem-Bekhit MM
    AAPS PharmSciTech; 2020 Jun; 21(5):168. PubMed ID: 32514657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tweak to Treat: Reprograming Bacteria for Cancer Treatment.
    Sieow BF; Wun KS; Yong WP; Hwang IY; Chang MW
    Trends Cancer; 2021 May; 7(5):447-464. PubMed ID: 33303401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting plug-and-play synthetic biology for drug discovery and production in microorganisms.
    Medema MH; Breitling R; Bovenberg R; Takano E
    Nat Rev Microbiol; 2011 Feb; 9(2):131-7. PubMed ID: 21189477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the structure of Escherichia coli outer membrane as the target for engineering microbial cell factories.
    Wang J; Ma W; Wang X
    Microb Cell Fact; 2021 Mar; 20(1):73. PubMed ID: 33743682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteria-cancer interactions: bacteria-based cancer therapy.
    Duong MT; Qin Y; You SH; Min JJ
    Exp Mol Med; 2019 Dec; 51(12):1-15. PubMed ID: 31827064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbes as Biosensors.
    Inda ME; Lu TK
    Annu Rev Microbiol; 2020 Sep; 74():337-359. PubMed ID: 32660390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress of engineered bacteria for tumour therapy.
    Xia X; Zhang JW; Zhao B; Zhang M; Chen ZR; Zhang BF; Ji YL; Wang X; Xiong WM; Li JW; Lv QL
    Int Immunopharmacol; 2024 May; 132():111935. PubMed ID: 38599096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic Biology for Specialty Chemicals.
    Markham KA; Alper HS
    Annu Rev Chem Biomol Eng; 2015; 6():35-52. PubMed ID: 26083056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical engineering of nanocarrier surfaces for an efficient drug delivery to severe diseases.
    Arias JL
    Curr Med Chem; 2012; 19(19):3069. PubMed ID: 22612711
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular Bioparticulates with Therapeutics for Cancer Immunotherapy.
    Wang C; Wen D; Gu Z
    Bioconjug Chem; 2018 Mar; 29(3):702-708. PubMed ID: 29227626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances of Bacterial Biomaterials for Disease Therapy.
    Zhai L; Fu L; Wei W; Zheng D
    ACS Synth Biol; 2024 May; 13(5):1400-1411. PubMed ID: 38605650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmable bacterial catalysis - designing cells for biosynthesis of value-added compounds.
    Lam CM; Suárez Diez M; Godinho M; Martins dos Santos VA
    FEBS Lett; 2012 Jul; 586(15):2184-90. PubMed ID: 22710181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.